Startups
Edit
Cleave Biosciences
http://www.cleavebio.com/Last activity: 06.07.2021
Active - Reference to Cleave Therapeutics
Discovering and developing novel small molecule therapies for difficult-to-treat cancers
Overview
Location
United States, California, Burlingame
Employees
11-50
Total raised
$47M
Founded date
2010
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 9, 2013 | Series A round | $10M |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 8, 2016 | Cleave Biosciences Raises $37M in Series B Financing | Cleave Biosciences, a Burlingame, CA-based biopharmaceutical company, completed a $37m Series B financing. Backers included new investors Celgene, Nextech Invest and Arcus Ventures as well as existing investors 5AM Ventures, Clarus Ventures... |
| Aug 8, 2016 | Cleave Biosciences Raises $37M Series B | BURLINGAME, CA, Cleave Biosciences today announced the completion of a $37 million Series B financing. >> Click here for more funding data on Cleave Biosciences >> To export Cleave Biosciences funding data to PDF and Excel, ... |
| Aug 8, 2016 | Startup targeting protein degradation in cancer raises $37M | To date the company has raised $91 million, that includes $54 million in a Series A round of financing that closed in 2013, said Laura Shawver, the founding CEO of Cleave Biosciences in a phone interview. The money will fund two Phase 1 cli... |
| Apr 9, 2013 | Cleave Biosciences Raises $10M in Series A Financing from New Enterprise Associates | Cleave Biosciences, a Burlingame, California-based developer of novel small molecule therapies for difficult-to-treat cancers, raised $10m in an extension of its Series A financing from new investor New Enterprise Associates (NEA). The comp... |
| Apr 9, 2013 | Cleave Biosciences Adds $10M to Series A | BURLINGAME, CA, Cleave Biosciences announced today it has raised $10 million in an extension of its Series A financing from new investor New Enterprise Associates. >> Click here for more funding data on Cleave Biosciences >>... |
| Apr 9, 2013 | NEA provides $10M to help fuel next-gen cancer R&D at Cleave | Closing in on the selection of its lead cancer program, San Francisco-based Cleave Biosciences has welcomed the deep-pocketed player New Enterprise Associates to its list of venture backers and topped up its Series A with a $10 million inve... |
| Oct 11, 2011 | Cleave Biosciences Raises $42M Series A | Newly established biopharmaceutical company discovering and developing novel therapies for cancer raised funds from U.S. Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors and Astellas Venture Management. >> Click he... |
| Oct 11, 2011 | Cleave Biosciences Raises $42M in Series A Financing | Cleave Biosciences, a Burlingame, California-based newly established biopharmaceutical company discovering and developing novel therapies for cancer, has raised $42m in Series A financing. Investors include U.S. Venture Partners, 5AM Ventur... |
| Startup targeting protein degradation in cancer raises $37M | Cleave Biosciences wants to cut protein pathway addiction to help kill off cancer cells in both solid tumors and blood cancers, and it just got $37 million to progress its agenda. The Burlingame, California, company announced Monday that it... |
Reviews 0
FAQ about Cleave Biosciences
When was Cleave Biosciences founded?
Cleave Biosciences was founded in 2010.
How much funding has Cleave Biosciences raised?
Cleave Biosciences has raised $47M in total across 2 funding rounds.
What funding rounds has Cleave Biosciences raised?
Parsers VC lists 2 funding rounds of Cleave Biosciences, among them a Series A round of $10M on Apr 9, 2013.
What has the press written about Cleave Biosciences?
Parsers VC has collected 10 articles mentioning Cleave Biosciences, among them “Cleave Biosciences Raises $37M in Series B Financing” (Aug 8, 2016) and “Cleave Biosciences Raises $37M Series B” (Aug 8, 2016).
Is Cleave Biosciences still active?
Yes, Cleave Biosciences is active; its latest activity on Parsers VC dates from Jul 6, 2021.